Literature DB >> 22626763

Acetylation and deacetylation--novel factors in muscle wasting.

Nima Alamdari1, Zaira Aversa, Estibaliz Castillero, Per-Olof Hasselgren.   

Abstract

We review recent evidence that acetylation and deacetylation of cellular proteins, including transcription factors and nuclear cofactors, may be involved in the regulation of muscle mass. The level of protein acetylation is balanced by histone acetyltransferases (HATs) and histone deacetylases (HDACs) and studies suggest that this balance is perturbed in muscle wasting. Hyperacetylation of transcription factors and nuclear cofactors regulating gene transcription in muscle wasting may influence muscle mass. In addition, hyperacetylation may render proteins susceptible to degradation by different mechanisms, including intrinsic ubiquitin ligase activity exerted by HATs and by dissociation of proteins from cellular chaperones. In recent studies, inhibition of p300/HAT expression and activity and stimulation of SIRT1-dependent HDAC activity reduced glucocorticoid-induced catabolic response in skeletal muscle, providing further evidence that hyperacetylation plays a role in muscle wasting. It should be noted, however, that although several studies advocate a role of hyperacetylation in muscle wasting, apparently contradictory results have also been reported. For example, muscle atrophy caused by denervation or immobilization may be associated with reduced, rather than increased, protein acetylation. In addition, whereas hyperacetylation results in increased degradation of certain proteins, other proteins may be stabilized by increased acetylation. Thus, the role of acetylation and deacetylation in the regulation of muscle mass may be both condition- and protein-specific. The influence of HATs and HDACs on the regulation of muscle mass, as well as methods to modulate protein acetylation, is an important area for continued research aimed at preventing and treating muscle wasting.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22626763      PMCID: PMC3430797          DOI: 10.1016/j.metabol.2012.03.019

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  115 in total

1.  p14ARF promotes RB accumulation through inhibition of its Tip60-dependent acetylation.

Authors:  C Leduc; P Claverie; B Eymin; E Col; S Khochbin; E Brambilla; S Gazzeri
Journal:  Oncogene       Date:  2006-02-27       Impact factor: 9.867

2.  Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1.

Authors:  Carolina Centeno-Baez; Patrice Dallaire; André Marette
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-02       Impact factor: 4.310

3.  Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappaB.

Authors:  Soichiro Usui; Yasuhiro Maejima; Jayashree Pain; Chull Hong; Jaeyeaon Cho; Ji Yeon Park; Daniela Zablocki; Bin Tian; David J Glass; Junichi Sadoshima
Journal:  Circ Res       Date:  2011-05-26       Impact factor: 17.367

Review 4.  Consequences of sarcopenia.

Authors:  Marjolein Visser; Laura A Schaap
Journal:  Clin Geriatr Med       Date:  2011-05-14       Impact factor: 3.076

5.  Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat.

Authors:  Iman Momken; Laurence Stevens; Audrey Bergouignan; Dominique Desplanches; Floriane Rudwill; Isabelle Chery; Alexandre Zahariev; Sandrine Zahn; T Peter Stein; Jean Louis Sebedio; Estelle Pujos-Guillot; Maurice Falempin; Chantal Simon; Véronique Coxam; Tany Andrianjafiniony; Guillemette Gauquelin-Koch; Florence Picquet; Stéphane Blanc
Journal:  FASEB J       Date:  2011-06-29       Impact factor: 5.191

6.  Association between muscle strength and metabolic syndrome in older Korean men and women: the Korean Longitudinal Study on Health and Aging.

Authors:  Eun Joo Yang; Soo Lim; Jae-Young Lim; Ki Woong Kim; Hak Chul Jang; Nam-Jong Paik
Journal:  Metabolism       Date:  2011-08-25       Impact factor: 8.694

7.  Mechanism of human SIRT1 activation by resveratrol.

Authors:  Margie T Borra; Brian C Smith; John M Denu
Journal:  J Biol Chem       Date:  2005-03-04       Impact factor: 5.157

Review 8.  The emerging role of epigenetic modifications and chromatin remodeling in spinal muscular atrophy.

Authors:  Sebastian Lunke; Assam El-Osta
Journal:  J Neurochem       Date:  2009-04-04       Impact factor: 5.372

9.  Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation.

Authors:  Masahiro Fukuoka; Hiroaki Daitoku; Mitsutoki Hatta; Hitomi Matsuzaki; Satoshi Umemura; Akiyoshi Fukamizu
Journal:  Int J Mol Med       Date:  2003-10       Impact factor: 4.101

10.  The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.

Authors:  David S Waddell; Leslie M Baehr; Jens van den Brandt; Steven A Johnsen; Holger M Reichardt; J David Furlow; Sue C Bodine
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-08       Impact factor: 4.310

View more
  20 in total

Review 1.  Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus.

Authors:  Linda Sommese; Alberto Zullo; Francesco Paolo Mancini; Rossella Fabbricini; Andrea Soricelli; Claudio Napoli
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

Review 2.  Expanding proteostasis by membrane trafficking networks.

Authors:  Darren M Hutt; William E Balch
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

3.  Immobilization induces nuclear accumulation of HDAC4 in rat skeletal muscle.

Authors:  Toshinori Yoshihara; Shuichi Machida; Yuka Kurosaka; Ryo Kakigi; Takao Sugiura; Hisashi Naito
Journal:  J Physiol Sci       Date:  2016-01-13       Impact factor: 2.781

4.  Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia.

Authors:  Yu-Chou Tseng; Samuel K Kulp; I-Lu Lai; En-Chi Hsu; Wei A He; David E Frankhouser; Pearlly S Yan; Xiaokui Mo; Mark Bloomston; Gregory B Lesinski; Guido Marcucci; Denis C Guttridge; Tanios Bekaii-Saab; Ching-Shih Chen
Journal:  J Natl Cancer Inst       Date:  2015-10-12       Impact factor: 13.506

5.  DNA methyltransferase 3a and mitogen-activated protein kinase signaling regulate the expression of fibroblast growth factor-inducible 14 (Fn14) during denervation-induced skeletal muscle atrophy.

Authors:  Marjan M Tajrishi; Jonghyun Shin; Michal Hetman; Ashok Kumar
Journal:  J Biol Chem       Date:  2014-06-03       Impact factor: 5.157

Review 6.  Epigenetic regulation of muscle phenotype and adaptation: a potential role in COPD muscle dysfunction.

Authors:  Esther Barreiro; Jacob I Sznajder
Journal:  J Appl Physiol (1985)       Date:  2013-01-10

Review 7.  Understanding the acetylome: translating targeted proteomics into meaningful physiology.

Authors:  Andrew Philp; Thomas Rowland; Joaquin Perez-Schindler; Simon Schenk
Journal:  Am J Physiol Cell Physiol       Date:  2014-09-03       Impact factor: 4.249

8.  Paracrine effects of IGF-1 overexpression on the functional decline due to skeletal muscle disuse: molecular and functional evaluation in hindlimb unloaded MLC/mIgf-1 transgenic mice.

Authors:  Sabata Pierno; Giulia M Camerino; Maria Cannone; Antonella Liantonio; Michela De Bellis; Claudio Digennaro; Gianluca Gramegna; Annamaria De Luca; Elena Germinario; Daniela Danieli-Betto; Romeo Betto; Gabriella Dobrowolny; Emanuele Rizzuto; Antonio Musarò; Jean-François Desaphy; Diana Conte Camerino
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

9.  Do epigenetic events take place in the vastus lateralis of patients with mild chronic obstructive pulmonary disease?

Authors:  Ester Puig-Vilanova; Pilar Ausin; Juana Martinez-Llorens; Joaquim Gea; Esther Barreiro
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

Review 10.  Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus.

Authors:  Karina Ramírez-Alarcón; Montserrat Victoriano; Lorena Mardones; Marcelo Villagran; Ahmed Al-Harrasi; Ahmed Al-Rawahi; Natália Cruz-Martins; Javad Sharifi-Rad; Miquel Martorell
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-01       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.